EPRX Stock Analysis: Buy, Sell, or Hold?
EPRX - Eupraxia Pharmaceuticals Inc. Common Stock
$7.17
-0.16 (-2.18%)
▼
5d:
+4.67%
30d:
-12.35%
90d:
-5.03%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 05, 2026
28d
Get Alerted When EPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: EPRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: EPRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: EPRX is currently trading at $7.17, which is considered slightly low relative to its 30-day fair value range of $7.04 to $8.00.
Technical Outlook: Technically, EPRX is in a uptrend. Immediate support is located at $6.56, while resistance sits at $7.62.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.39 (+100.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EPRX is in a uptrend. Immediate support is located at $6.56, while resistance sits at $7.62.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.39 (+100.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.04 -
$8.00
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.7% below Wall St target ($14.39)
Fair Price Analysis
30-Day Fair Range
$7.04 -
$8.00
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.56
Resistance Level
$7.62
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.16
Wall Street Target
$14.39
(+100.7%)
Share & Embed Analysis
Last updated: April 06, 2026 8:52 AM ET
Data refreshes hourly during market hours. Next update: 9:52 AM
Data refreshes hourly during market hours. Next update: 9:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EPRX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
